PharmaEssentia: Board of Directors Resolves to Repurchase and Cancel Restricted Stock Units for Employees and Sets Capital Reduction Record Date
NQ Score
0/100
N1 Content Completeness
5
AI Summary (NQ-processed)
PharmaEssentia announced that its Board of Directors resolved to repurchase and cancel restricted stock units (RSUs) due to employee resignations, in accordance with its RSU issuance regulations. This will lead to a capital reduction of NTD 80,000, eliminating 8,000 shares, with the capital reduction record date set for May 13, 2026.